Tech Company Financing Transactions
JIXING Pharmaceuticals Funding Round
Bayer and RTW Investments participated in a $162 million funding round for JIXING Pharmaceuticals. This venture round was announced on 1/10/2024.
Transaction Overview
Company Name
Announced On
1/10/2024
Transaction Type
Venture Equity
Amount
$162,000,000
Round
Undisclosed
Investors
Bayer (Zhou Xiaolan)
RTW Investments (Roderick Wong)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
22F, JC Plaza, 1225 West Nanjing Road Jing'an District
Shanghai, 200040
China
Shanghai, 200040
China
Phone
Website
Email Address
Overview
JIXING is a leading biotechnology company headquartered in Shanghai committed to bringing innovative science and medicines to underserved Chinese patients with serious and life-threatening diseases. JIXING was founded in 2019 and partners with global biotechnology companies to develop and commercialize novel, innovative therapeutics to treat unmet medical needs in cardiovascular and ophthalmic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sandy Mou
Chief Financial Officer
Lisa Tian
Chief Medical Officer
Edmond Chen
Chief Medical Officer
Larry Li
Chief Medical Officer
Yuan Li
Chief Technical Officer
Horch Guo
VP - Bus. Development
Ying Wang
VP - General Counsel
John Li
VP - Human Resources
Christine Dai
VP - Marketing
Zhichao Si
VP - Operations
Yi Yan
VP - Regulatory Affairs
Rainy Zhou
Browse more venture capital transactions:
Prev: 1/9/2024: Matr1x venture capital transaction
Next: 1/10/2024: VoicePing venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs